Spro investors have opportunity to lead spero therapeutics, inc. securities fraud lawsuit

Los angeles , july 21, 2022 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against spero therapeutics, inc. ("spero" or the "company") (nasdaq: spro). class period: may 6, 2021 – may 2, 2022 lead plaintiff deadline: july 25, 2022 if you wish to serve as lead plaintiff of the spero lawsuit, you can submit your contact information at www.glancylaw.com/cases/spero-therapeutics-inc/.
SPRO Ratings Summary
SPRO Quant Ranking